GHSI: שולי רווח תפעולי Guardion Health Science

Guardion Health Science (GHSI) is winding down its operations, distributing capital to shareholders following the sale of its assets. The business previously relied on recurring sales of specialized nutraceuticals, which provided a stable cash flow. The integration of diagnostics with nutrition created a unique ecosystem for ophthalmologists. Operating margin dynamics demonstrate current resilience, where the value of -41.20 corresponds to the current metric.
Guardion Health Science - פילוחים אנליטיים ומדדי מפתח (GHSI)

The market consensus regarding the prospects of Guardion Health Science (GHSI) is based on an analysis of the operating margin, calculated as the ratio of operating income to total revenue to assess the efficiency of the business model. The history of operating profitability reflects the company's ability to monetize the uniqueness of Lumega-Z formulas through low demand elasticity, characterizing this asset as a high-margin niche business.